New York Times Co: Form 10-K for the period ended Dec 31, 2022
Filed with the SEC on Feb 28, 2023 and accepted by EDGAR at Feb 28, 2023, 16:09 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2022-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2021-12-27 to 2022-12-31 | $2.31bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Research and development | 3 months2022-09-26 to 2022-12-31 | $204.2m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 12 months2021-12-27 to 2022-12-31 | $204.2m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months2021-12-27 to 2022-12-31 | $202.0m | us-gaap:OperatingIncomeLoss |
| Income tax | 12 months2021-12-27 to 2022-12-31 | $62.1m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2021-12-27 to 2022-12-31 | $173.9m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2021-12-27 to 2022-12-31 | $1.04 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2021-12-27 to 2022-12-31 | $1.04 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2021-12-27 to 2022-12-31 | 167,141,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2021-12-27 to 2022-12-31 | $150.7m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2021-12-27 to 2022-12-31 | $37.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 12 months2021-12-27 to 2022-12-31 | $56.8m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 12 months2021-12-27 to 2022-12-31 | $105.1m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2022-12-31 | $221.4m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2022-12-31 | $655.7m | us-gaap:AssetsCurrent |
| Total assets | At period end2022-12-31 | $2.53bn | us-gaap:Assets |
| Current liabilities | At period end2022-12-31 | $571.2m | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | At period end2022-12-31 | $1.60bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000071691-23-000006. Last ingested by Listed: Nov 4, 2026, 14:15 ET. Listed shows no prices and gives no investment advice.